Key facts
- Notable investors include Ancheng Capital, Jiangsu Lianhuan Pharmaceutical Group.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Kanghetcm
- ·The full record, as it builds
Funding rounds
No funding rounds for Kanghetcm are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kanghetcm
Operator of a pharmaceutical company focused on traditional Chinese medicine. The company offers Chinese herbal medicine slices, toxic herbal medicine slices and directly oral herbal medicine slices, catering to clients with hometown of medicinal materials.
- Sector
- Healthcare
- HQ
- Bozhou, China
- Founded
- 2017
- Employees
- 200
- Website
- ahkanghe.cn/
- Ownership
- Privately Held (backing)
Kanghetcm doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kanghetcm shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kanghetcm in its N-PORT filings yet. We sweep new filings monthly.